SCH 58500: Halted Phase II trials

Separately, Rhone-Poulenc Rorer Inc. (Collegeville, Penn.) said that its gene therapy trials are ongoing, including those investigating INGN 201 (Adenoviral-p53) in oncology in collaboration with In...